Predictive Oncology
EAGAN, Minnesota, United States · Artificial Intelligence, Biotechnology, Blockchain
Predictive Oncology is on a mission to transform oncology drug discovery and drive the development of more effective cancer therapies. By leveraging machine learning, scientific expertise, and biologics, we work to increase the probability of success and advance drug compounds with greater precision and confidence.
Key facts
- Headquarters
- EAGAN, Minnesota, United States
- Employees
- 20
- Industries
- Artificial Intelligence, Biotechnology, Blockchain
- Status
- Public (AGPU)
- Website
- precisiontherapeutics.com
- Company page
Recent activity at Predictive Oncology
- : SEC 8-K (1.01): On September 30, 2026, Axe Compute Inc. entered into a Material Definitive Agreement to acquire 100% of the membership interests in Duos Edge AI – GPUaaS, LLC (the 'SPV'), which was wholly-owned by Duos Technologies Group, Inc. The SPV's assets include 288 Supermicro B300 servers with 2,304 GPUs and associated networking equipment. The total consideration for this acquisition involved repayment of the SPV’s pre-existing debt of approximately $87.8 million and an additional deferred purchase price of $715,000 monthly for 60 months. This acquisition strengthens Axe Compute's capabilities in GPU-as-a-Service offerings, impacting its market position significantly.
- : SEC 8-K (1.01):
- : SEC 8-K (8.01): On August 17, 2026, Axe Compute Inc. announced through a press release that it has entered into agreements with Duos Technologies Group, Inc. to establish 55 MW of new AI data center capacity across multiple locations in the U.S., with over $500 million in expected aggregate payments. The agreements include nonbinding term sheets for minority equity investments whereby Axe Compute is expected to hold 49% of the equity interests in the associated entities. This strategic collaboration highlights the company's continued expansion in the AI sector and its efforts to meet future infrastructure demands.
- : SEC 8-K (8.01): On July 27, 2026, Axe Compute Inc. announced via press release that it has secured a new five-year customer agreement with a total contract value exceeding $1.5 billion. This agreement involves deploying a dedicated AI infrastructure cluster in the United States as part of the Axe Compute Build program. The contract is expected to significantly enhance the company's capabilities and revenue over the lifespan of the agreement. The press release includes forward-looking statements regarding the project's scope, anticipated revenue contributions, and other strategic implications for the company's future growth and infrastructure requirements.
- : SEC 8-K (8.01): On July 22, 2026, Axe Compute Inc. announced through a press release that it has secured over $1.3 billion in new customer contracts throughout the United States and Europe via its Axe Compute Build program. This development represents a significant expansion of the company's business operations and is expected to impact its future revenue positively. The announcement is part of a broader strategy to enhance the company's global presence and infrastructure capabilities. The press release, filed as Exhibit 99.1, includes forward-looking statements related to project configurations, anticipated revenue contributions, and customer demands for future infrastructure needs.
- : SEC 8-K (8.01):
- : SEC 8-K (8.01): On May 15, 2026, Axe Compute Inc. filed a prospectus supplement to update its ATM Prospectus and amend the ATM Sales Agreement made with H.C. Wainwright & Co., LLC on May 3, 2024. The amendment updates the maximum amount of shares of common stock eligible for sale to $100,000,000, following the removal of limitations from General Instruction I.B.6 of Form S-3. As of this date, the company has sold approximately $12.7 million in securities within the past year. The filing is intended for informational purposes only and does not constitute an offer to sell or a solicitation of offers to buy under the securities laws.
- : SEC 8-K (7.01):
- : SEC 8-K (8.01): On April 22, 2026, Axe Compute Inc. announced its entry into a significant 36-month enterprise infrastructure contract valued at approximately $260 million with an enterprise customer. This agreement marks the largest enterprise engagement in the Company's history, involving the delivery of a dedicated cluster comprising 2,304 NVIDIA B300 GPUs and AI-focused high-speed storage infrastructure based in a U.S. Tier 3 data center. Deployment is set to commence in the third quarter of 2026, and the contract includes options for renewal beyond the initial term. The payment structure consists of a deposit, prepayment, and monthly payments on a take-or-pay basis, ensuring elevated service levels throughout the duration of the contract.
- : SEC 8-K (5.02): On April 16, 2026, Axe Compute Inc. appointed Jeremy Yaukey-Witter as co-Chief Financial Officer, effective immediately, due to the resignation of current CFO Josh Blacher, who will continue in the role until May 18, 2026. Yaukey-Witter's appointment involves an employment agreement that includes an annual salary of $280,000 and eligibility for performance-based bonuses and stock options. There are no reported disagreements related to Blacher's resignation. Yaukey-Witter, a Certified Public Accountant with experience at KPMG, will take on the sole CFO position after Blacher's departure, marking a significant transition in the Company's executive leadership amidst a defined timeline and compensation structure.
Predictive Oncology funding history
| Date | Round | Amount |
|---|---|---|
| Oct 2025 | Venture | $173.3M |
| Oct 2025 | Venture | $50.8M |
| Sep 2025 | Seed | $413K |
| Aug 2024 | Venture | $2.2M |
| Jun 2022 | Venture | $2.3M |
Leadership
- Ivan, Director, Quality Assurance
- Raymond, Director of IT Operations
- Arlette, Sr VP Translational Medicine and Drug Discovery, Medical Director
- Robert, Senior Director of Bioinformatics
- J Engle, Executive Officer, Director
- Chuck Nuzum, Director
- Daniel Handley, Director
- Gregory Clair, Director
- Nancy Chung-Welch, Director
- Raymond Vennare, Director
- Christina Jenkins, Director
- J Engle, Executive Officer, Director
Verified email and direct lines for Predictive Oncology’s decision-makers are on Fundz. See plans — or book a 15-minute walkthrough.
Employee benefit plans
Predictive Oncology files 1 employee benefit plan with the U.S. Department of Labor, including a retirement plan. The next plan year renews in Dec 2026.
Companies similar to Predictive Oncology
- Corvex Legacy Holdings · Artificial Intelligence, Biotechnology, Healthcare, Information Technology
- I Synergy Group · Artificial Intelligence, Blockchain, Cryptocurrency, Information Technology
- Block Intelligence · Artificial Intelligence, Blockchain, Cryptocurrency, Information Technology
- HIVE Digital Technologies Ltd · Artificial Intelligence, Blockchain, Cryptocurrency, Information Technology
- RITTER PHARMACEUTICALS INC · Artificial Intelligence, Biotechnology, Blockchain, Cryptocurrency
About Predictive Oncology: questions and answers
What does Predictive Oncology do?
Predictive Oncology is on a mission to transform oncology drug discovery and drive the development of more effective cancer therapies. By leveraging machine learning, scientific expertise, and biologics, we work to increase the probability of success and advance drug compounds with greater precision and confidence.
Where is Predictive Oncology headquartered?
Predictive Oncology is headquartered in EAGAN, Minnesota, United States.
How many employees does Predictive Oncology have?
Predictive Oncology has about 20 employees.
Has Predictive Oncology raised funding?
Yes. Fundz has recorded 5 funding events for Predictive Oncology. The most recent, $173.3M, was in Oct 2025.
What is the latest news on Predictive Oncology?
On Sep 30, 2026, SEC 8-K (1.01): On September 30, 2026, Axe Compute Inc. entered into a Material Definitive Agreement to acquire 100% of the membership interests in Duos Edge AI – GPUaaS, LLC (the 'SPV'), which was wholly-owned by Duos Technologies Group, Inc. The SPV's assets include 288 Supermicro B300 servers wit
Is Predictive Oncology a public company?
Yes. Predictive Oncology is publicly traded under the ticker AGPU.
Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy